Litcius/Paper detail

Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.

Chezi Ganzel, Eli Ben‐Chetrit

2021PubMed16 citations

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyImmunologyPathologyInfectious disease (medical specialty)OutbreakDiseasePlatelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and ThrombosisBlood groups and transfusion
Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. | Litcius